Pear Therapeutics

Pear Therapeutics, Inc. (PEAR), is a venture-backed digital health company focused on the development of digital therapies and drug/software combinations to treat diseases with high unmet medical need.

Industries

Stage

Post IPO Equity

Employees

201-500

Links

Org chart

Corey Mccann
President & CEO
Collapse
Erin Brenner
Chief Product Development Officer
Brian Prunier
VP, Patient Services
Chris Guiffre
CFO & COO
Yuri Maricich
Chief Medical Officer & Head of Development
Ronan O’brien
General Counsel, Chief Compliance Officer & Secretary
Catherine Cushenberry
VP, Business Programs
Beth Keyt
VP, Government Affairs & Market Access
Anthony Watson
VP, Regulatory Affairs
Chris Valosky
VP, Sales, Commercial Partnership & Marketing
Maria Sullivan
VP, Clinical Development
Martha Carruthers
VP, Corporate Development
Frances Thorndike
VP, Medical Affairs & Discovery
Two candidates
The Org
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.